Alignment Healthcare Announces Pricing of Secondary Offering

Affiliate of General Atlantic, L.P. to sell 13.2 million shares of common stock

Published on Mar. 2, 2026

Got story updates? Submit your updates here. ›

Alignment Healthcare, Inc., an award-winning Medicare Advantage company, announced the pricing of a previously announced underwritten public offering of 13,167,733 shares of its common stock by an affiliate of General Atlantic, L.P. The shares will be sold at a public offering price of $19.46 per share, and Alignment Healthcare will not receive any of the proceeds from the sale.

Why it matters

This secondary offering allows an existing investor, General Atlantic, to sell a portion of its stake in Alignment Healthcare, which could provide liquidity for the private equity firm and potentially increase the public float of Alignment's stock.

The details

The underwritten public offering is expected to close on March 4, 2026, subject to customary closing conditions. J.P. Morgan is acting as the sole underwriter for the offering, which is being made pursuant to a shelf registration statement filed with the SEC.

  • The offering is expected to close on March 4, 2026.

The players

Alignment Healthcare, Inc.

An award-winning Medicare Advantage company based in Orange, California.

General Atlantic, L.P.

A private equity firm that is the selling stockholder in this secondary offering.

J.P. Morgan

The underwriter for the public offering.

Got photos? Submit your photos here. ›

The takeaway

This secondary offering allows an existing investor to monetize a portion of its stake in Alignment Healthcare, which could provide liquidity and potentially increase the public float of the company's stock.